Making Abortion Services Accessible in the Wake of Legal Reforms: a Framework and Six Case Studies
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Conscientious Objection to Abortion Provision in Bogota, Colombia: Religion, Respect, and Referral Authors: Lauren R
Conscientious objection to abortion provision in Bogota, Colombia: religion, respect, and referral Authors: Lauren R. Fink, Kaitlyn K. Stanhope, Chelsey E. Brack, Kalie E. Richardson, Roger W. Rochat, MD, Oscar A Bernal, MPH, MD, PhD Affiliations: Emory University Rollins School of Public Health (LRF, KKS, CEB, RWR), Emory University School of Law (KER), University of the Andes (OAB) Background Each year, an estimated 68,000 women die from unsafe abortions (Grimes et al., 2006), and eight million experience complications requiring medical attention, though only five million receive care (Johnson, Kismödi, Dragoman, & Temmerman, 2013). When women have access to safe and legal abortion services, the vast majority of abortion-related morbidity and mortality is eliminated, while the overall incidence of abortion remains approximately equal (Grimes et al., 2006). Criminalization severely restricts women’s access to safe services, but even after abortion is decriminalized, procedural, economic, informational, and cultural barriers continue to impede access to legal abortion services in many countries (Ashford, Sedgh, & Singh, 2012; Johnson et al., 2013). Some of these barriers emerge in the patient- provider relationship, including failure to refer and conscientious objection (International Sexual and Reproductive Health Law Programme, 2008). Conscientious objection – in which healthcare professionals are exempted from providing or participating in abortion care on religious, moral or philosophical grounds – presents a particular litigious -
Personhood Seeking New Life with Republican Control Jonathan Will Mississippi College School of Law, [email protected]
Mississippi College School of Law MC Law Digital Commons Journal Articles Faculty Publications 2018 Personhood Seeking New Life with Republican Control Jonathan Will Mississippi College School of Law, [email protected] I. Glenn Cohen Harvard Law School, [email protected] Eli Y. Adashi Brown University, [email protected] Follow this and additional works at: https://dc.law.mc.edu/faculty-journals Part of the Health Law and Policy Commons Recommended Citation 93 Ind. L. J. 499 (2018). This Article is brought to you for free and open access by the Faculty Publications at MC Law Digital Commons. It has been accepted for inclusion in Journal Articles by an authorized administrator of MC Law Digital Commons. For more information, please contact [email protected]. Personhood Seeking New Life with Republican Control* JONATHAN F. WILL, JD, MA, 1. GLENN COHEN, JD & ELI Y. ADASHI, MD, MSt Just three days prior to the inaugurationof DonaldJ. Trump as President of the United States, Representative Jody B. Hice (R-GA) introducedthe Sanctity of Human Life Act (H R. 586), which, if enacted, would provide that the rights associatedwith legal personhood begin at fertilization. Then, in October 2017, the Department of Health and Human Services releasedits draft strategicplan, which identifies a core policy of protectingAmericans at every stage of life, beginning at conception. While often touted as a means to outlaw abortion, protecting the "lives" of single-celled zygotes may also have implicationsfor the practice of reproductive medicine and research Indeedt such personhoodefforts stand apart anddistinct from more incre- mental attempts to restrictabortion that target the abortionprocedure and those who would perform it. -
Motherhood Or Punishment. Criminalizing Abortion In
/ Motherhood or Punishment Criminalizing Abortion in Mexico SECCIÓN 2 SECCIÓN 4 SECCIÓN 5 GIRE ACKNOWLEDGEMENTS Direction Communications Institutional public policy advocacy Gire’s advisory board REGINA TAMÉS BRENDA RODRÍGUEZ Development REBECA RAMOS MARTA LAMAS JIMENA SORIA DUNIA CAMPOS JENNIFER PAINE FRANCISCO CUÉ MARTÍNEZ GERARDO BARROSO OMAR FELICIANO JULIETA HERRERA ALEJANDRO GALLAND LUISA CABAL Administration MARTY MINNICH ANTONINA WEBER REBECA LOREA ROY CAMPOS SILVIA GARCÍA ELENA ROJAS GENARO LOZANO STEFANI DURÁN Case documentation research FRANCISCA POU KARLA IBERIA SÁNCHEZ CATALINA GONZÁLEZ Accounting and litigation ISABEL FULDA MARÍA LUISA SÁNCHEZ FUENTES MARIO MACÍAS ROSA MARÍA ROSAS ALEX ALÍ MÉNDEZ VALENTINA GÓMEZ CECILIA SUÁREZ MICAELA MACÍAS MARGARITA GONZÁLEZ JACQUELINE ÁLVAREZ KAREN LUNA ROBERTO TAPIA PABLO ORTEGA SUSANA IBARREN ELBA ARAGÓN MARIANA ROCA RODOLFO VÁZQUEZ KAREN MEDINA ALEHÍ BALDERAS CECILIA RODRÍGUEZ JOSÉ WOLDENBERG SAÚL MEZA OFELIA BASTIDA YOLANDA MOLINA MARCO MORENO EDITORIAL CREDITS Direction Information Photography REGINA TAMÉS requests CLAUDIA GUADARRAMA VALENTINA GÓMEZ coordination IVANNA RAMOS Design ISABEL FULDA MARTIN VERA DATA CÍVICA MARÍA CARRAL Research and text Editorial supervision ELENA ROJAS ISABEL FULDA MARIANA ROCA KAREN LUNA MARIANA ROCA gire would like to thank Asistencia Legal por los Derechos Humanos (AsiLegal) for their collaboration in the development of this report. Motherhood or punishment. Criminalizing abortion in Mexico gire’s work is supported by individual donors and foundations, including: two anonymous donors; 2018 (English version, 2019) the European Union; the Ford Foundation Office for Mexico and Central America; the William and Grupo de Información en Reproducción Elegida, A.C. Flora Hewlett Foundation; the W.K. Kellogg Foundation; the John D. and Catherine T. Macarthur Coyoacán, C.P. -
She Is Not a Criminal
SHE IS NOT A CRIMINAL THE IMPACT OF IRELAND’S ABORTION LAW Amnesty International is a global movement of more than 7 million people who campaign for a world where human rights are enjoyed by all. Our vision is for every person to enjoy all the rights enshrined in the Universal Declaration of Human Rights and other international human rights standards. We are independent of any government, political ideology, economic interest or religion and are funded mainly by our membership and public donations. First published in 2015 by Amnesty International Ltd Peter Benenson House 1 Easton Street London WC1X 0DW United Kingdom © Amnesty International 2015 Index: EUR 29/1597/2015 Original language: English Printed by Amnesty International, International Secretariat, United Kingdom All rights reserved. This publication is copyright, but may be reproduced by any method without fee for advocacy, campaigning and teaching purposes, but not for resale. The copyright holders request that all such use be registered with them for impact assessment purposes. For copying in any other circumstances, or for reuse in other publications, or for translation or adaptation, prior written permission must be obtained from the publishers, and a fee may be payable. To request permission, or for any other inquiries, please contact [email protected] Cover photo: Stock image: Female patient sitting on a hospital bed. © Corbis amnesty.org CONTENTS 1. Executive summary ................................................................................................... 6 -
Exploring Organizations and Advocacy STRATEGIES and FINANCES
NONPROFIT ADVOCACY AND THE POLICY PROCESS A SEMINAR SERIES VOLUME 2 Exploring Organizations and Advocacy STRATEGIES AND FINANCES ISSUE 1 Edited by Elizabeth J. Reid and Maria D. Montilla The Urban Institute NONPROFIT ADVOCACY AND THE POLICY PROCESS A SEMINAR SERIES VOLUME 2 Exploring Organizations and Advocacy STRATEGIES AND FINANCES ISSUE 1 Edited by Elizabeth J. Reid and Maria D. Montilla The Urban Institute Acknowledgments We wish to thank the seminar cohosts, Evelyn Brody and Frances Hill, the authors, and the seminar participants who contributed valuable insights to the seminars and to the volume. CNP staff, especially Pho Palmer, provided valuable assistance to the project. Nonprofit Advocacy and the Policy Process: A Seminar Series Advisory Panel Members Audrey Alvarado Debra Minkoff National Council for Yale University Nonprofit Associations Department of Sociology Elizabeth T. Boris John Pomeranz Center on Nonprofits and Philanthropy Alliance for Justice The Urban Institute Elizabeth J. Reid Evelyn Brody Center on Nonprofits and Philanthropy Chicago-Kent College The Urban Institute Illinois Institute of Technology School of Law Peter Shiras Independent Sector Rosemary E. Fei Silk, Adler & Colvin C. Eugene Steuerle The Urban Institute Frances Hill University of Miami School of Law Leslie Lenkowsky Indiana University Center on Philanthropy Copyright © August 2001. The Urban Institute. All rights reserved. Except for short quotes, no part of this book may be reproduced or utilized in any form or by any means, electronic or mechanical, in- cluding photocopying, recording, or by information storage or retrieval system, without written per- mission from the Urban Institute. The nonpartisan Urban Institute publishes studies, reports, and books on timely topics worthy of pub- lic consideration. -
TA(2020)0336 Abortion Rights in Poland European Parliament Resolution of 26 November 2020 on the De Facto Ban on the Right to Abortion in Poland (2020/2876(RSP))
European Parliament 2019-2024 TEXTS ADOPTED P9_TA(2020)0336 Abortion rights in Poland European Parliament resolution of 26 November 2020 on the de facto ban on the right to abortion in Poland (2020/2876(RSP)) The European Parliament, – having regard to the Treaty on European Union (TEU), and in particular Articles 2 and 7(1) thereof, – having regard to the European Convention on Human Rights (ECHR) of 4 November 1950 and the related case law of the European Court of Human Rights (ECtHR), – having regard to the Charter of Fundamental Rights of the European Union (‘the Charter’), – having regard to the Constitution of the Republic of Poland, – having regard to the Universal Declaration of Human Rights of 10 December 1948, – having regard to the UN International Covenant on Economic, Social and Cultural Rights (ICESCR) of 16 December 1966 and the UN International Covenant on Civil and Political Rights (ICCPR) of 16 December 1966, – having regard to the Convention on the Elimination of all Forms of Discrimination against Women of 18 December 1979, – having regard to the UN Convention against Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment of 10 December 1984, – having regard to the UN Human Rights Committee’s concluding observations of 23 November 2016 on the seventh periodic report of Poland, – having regard to UNESCO’s International Technical Guidance on Sexuality Education of 10 January 2018, – having regard to the International Conference on Population and Development (ICPD) held in Cairo in 1994, its programme of -
Mifepristone
1. NAME OF THE MEDICINAL PRODUCT Mifegyne 200 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 200-mg mifepristone. For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablet. Light yellow, cylindrical, bi-convex tablets, with a diameter of 11 mm with “167 B” engraved on one side. 4. CLINICAL PARTICULARS For termination of pregnancy, the anti-progesterone mifepristone and the prostaglandin analogue can only be prescribed and administered in accordance with New Zealand’s abortion laws and regulations. 4.1 Therapeutic indications 1- Medical termination of developing intra-uterine pregnancy. In sequential use with a prostaglandin analogue, up to 63 days of amenorrhea (see section 4.2). 2- Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester. 3- Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reasons (beyond the first trimester). 4- Labour induction in fetal death in utero. In patients where prostaglandin or oxytocin cannot be used. 4.2 Dose and Method of Administration Dose 1- Medical termination of developing intra-uterine pregnancy The method of administration will be as follows: • Up to 49 days of amenorrhea: 1 Mifepristone is taken as a single 600 mg (i.e. 3 tablets of 200 mg each) oral dose, followed 36 to 48 hours later, by the administration of the prostaglandin analogue: misoprostol 400 µg orally or per vaginum. • Between 50-63 days of amenorrhea Mifepristone is taken as a single 600 mg (i.e. 3 tablets of 200 mg each) oral dose, followed 36 to 48 hours later, by the administration of misoprostol. -
“Why Do They Want to Make Me Suffer Again?” the Impact of Abortion Prosecutions in Ecuador
HUMAN “Why Do They Want to RIGHTS WATCH Make Me Suffer Again?” The Impact of Abortion Prosecutions in Ecuador “Why Do They Want to Make Me Suffer Again?” The Impact of Abortion Prosecutions in Ecuador Copyright © 2021 Human Rights Watch All rights reserved. Printed in the United States of America ISBN: 978-1-62313-919-3 Cover design by Rafael Jimenez Human Rights Watch defends the rights of people worldwide. We scrupulously investigate abuses, expose the facts widely, and pressure those with power to respect rights and secure justice. Human Rights Watch is an independent, international organization that works as part of a vibrant movement to uphold human dignity and advance the cause of human rights for all. Human Rights Watch is an international organization with staff in more than 40 countries, and offices in Amsterdam, Beirut, Berlin, Brussels, Chicago, Geneva, Goma, Johannesburg, London, Los Angeles, Moscow, Nairobi, New York, Paris, San Francisco, Sydney, Tokyo, Toronto, Tunis, Washington DC, and Zurich. For more information, please visit our website: http://www.hrw.org JULY 2021 ISBN: 978-1-62313-919-3 “Why Do They Want to Make Me Suffer Again?” The Impact of Abortion Prosecutions in Ecuador Summary ........................................................................................................................... 1 Key Recommendations ....................................................................................................... 8 To the Presidency ................................................................................................................... -
Recent Abortion Law Reforms (Or Much Ado About Nothing) Harvey L
Journal of Criminal Law and Criminology Volume 60 | Issue 1 Article 2 1969 Recent Abortion Law Reforms (Or Much Ado About Nothing) Harvey L. Ziff Follow this and additional works at: https://scholarlycommons.law.northwestern.edu/jclc Part of the Criminal Law Commons, Criminology Commons, and the Criminology and Criminal Justice Commons Recommended Citation Harvey L. Ziff, Recent Abortion Law Reforms (Or Much Ado About Nothing), 60 J. Crim. L. Criminology & Police Sci. 3 (1969) This Article is brought to you for free and open access by Northwestern University School of Law Scholarly Commons. It has been accepted for inclusion in Journal of Criminal Law and Criminology by an authorized editor of Northwestern University School of Law Scholarly Commons. THE JounN.e., or CatnaA, LAw, CRIMnOLOGY AND POLICE SCIENCE Vol. 60, No. 1 Copyright @ 1969 by Northwestern University School of Law Pri ed in U.S.A. RECENT ABORTION LAW REFORMS (OR MUCH ADO ABOUT NOTHING) HARVEY L. ZIFF The author is a graduate of Northwestern University School of Law's two-year Prosecution-Defense Graduate Student Program. He received his LL.M. degree in June, 1969, after completing one year in residence and one year in the field as an Assistant United States Attorney in San Francisco, Califor- nia. The present article was prepared in satisfaction of the graduate thesis requirement. (It repre- sents the author's own views and in no way reflects the attitude of the Office of United States Attorney.) Mr. Ziff received his B.S. degree in Economics from the Wharton School of Finance of the Univer- sity of Pennsylvania in 1964. -
Nurse Versus Physician-Provision Of
Research Nurse versus physician-provision of early medical abortion in Mexico: a randomized controlled non-inferiority trial Claudia Diaz Olavarrieta,a Bela Ganatra,b Annik Sorhaindo,c Tahilin S Karver,c Armando Seuc,b Aremis Villalobos,a Sandra G García,c Martha Pérez,d Manuel Bousieguezc & Patricio Sanhuezad Objective To examine the effectiveness, safety, and acceptability of nurse provision of early medical abortion compared to physicians at three facilities in Mexico City. Methods We conducted a randomized non-inferiority trial on the provision of medical abortion and contraceptive counselling by physicians or nurses. The participants were pregnant women seeking abortion at a gestational duration of 70 days or less. The medical abortion regimen was 200 mg of oral mifepristone taken on-site followed by 800 μg of misoprostol self–administered buccally at home 24 hours later. Women were instructed to return to the clinic for follow-up 7–15 days later. We did an intention-to-treat analysis for risk differences between physicians’ and nurses’ provision for completion and the need for surgical intervention. Findings Of 1017 eligible women, 884 women were included in the intention-to-treat analysis, 450 in the physician-provision arm and 434 in the nurse-provision arm. Women who completed medical abortion, without the need for surgical intervention, were 98.4% (443/450) for physicians’ provision and 97.9% (425/434) for nurses’ provision. The risk difference between the group was 0.5% (95% confidence interval, CI: −1.2% to 2.3%). There were no differences between providers for examined gestational duration or women’s contraceptive method uptake. -
Abortion in Africa
FACT SHEET Abortion in Africa Incidence and Trends Southern Africa, rates are close to the and Cape Verde, Mozambique, South ■■ During 2010–2014, an estimated 8.3 regional average of 34 per 1,000. Africa and Tunisia allow pregnancy million induced abortions occurred termination without restriction as to each year in Africa. This number ■■ The proportion of pregnancies reason, but with gestational limits. represents an increase from 4.6 million ending in abortion ranges from 12% annually during 1990–1994, mainly in Western Africa to 23% and 24% Unsafe Abortion and Its because of an increase in the number in Northern and Southern Africa, Consequences of women of childbearing age. respectively. It is 13% and 14% in ■■ Although induced abortion is medi- Middle and Eastern Africa, respectively. cally safe when done in accordance ■■ The annual rate of abortion, estimated with recommended guidelines, many at 34 procedures per 1,000 women Legal Status of Abortion women undergo unsafe procedures of childbearing age (i.e., those 15–44 ■■ As of 2015, an estimated 90% of that put their well-being at risk. years old), remained more or less women of childbearing age in Africa constant over the same period. live in countries with restrictive abor- ■■ Where abortion is restricted, women tion laws (i.e., countries falling into the often resort to clandestine procedures, ■■ The abortion rate is roughly 26 for first four categories in Table 2). Even which are often unsafe—performed married women and 36 for unmarried where the law allows abortion under by individuals lacking the necessary women. limited circumstances, it is likely that skills or in an environment lacking the few women in these countries are able minimal medical standards, or both. -
Medical Abortion Reference Guide INDUCED ABORTION and POSTABORTION CARE at OR AFTER 13 WEEKS GESTATION (‘SECOND TRIMESTER’) © 2017, 2018 Ipas
Medical Abortion Reference Guide INDUCED ABORTION AND POSTABORTION CARE AT OR AFTER 13 WEEKS GESTATION (‘SECOND TRIMESTER’) © 2017, 2018 Ipas ISBN: 1-933095-97-0 Citation: Edelman, A. & Mark, A. (2018). Medical Abortion Reference Guide: Induced abortion and postabortion care at or after 13 weeks gestation (‘second trimester’). Chapel Hill, NC: Ipas. Ipas works globally so that women and girls have improved sexual and reproductive health and rights through enhanced access to and use of safe abortion and contraceptive care. We believe in a world where every woman and girl has the right and ability to determine her own sexuality and reproductive health. Ipas is a registered 501(c)(3) nonprofit organization. All contributions to Ipas are tax deductible to the full extent allowed by law. For more information or to donate to Ipas: Ipas P.O. Box 9990 Chapel Hill, NC 27515 USA 1-919-967-7052 [email protected] www.ipas.org Cover photo: © Ipas The photographs used in this publication are for illustrative purposes only; they do not imply any particular attitudes, behaviors, or actions on the part of any person who appears in the photographs. Printed on recycled paper. Medical Abortion Reference Guide INDUCED ABORTION AND POSTABORTION CARE AT OR AFTER 13 WEEKS GESTATION (‘SECOND TRIMESTER’) Alison Edelman Senior Clinical Consultant, Ipas Professor, OB/GYN Oregon Health & Science University Alice Mark Associate Medical Director National Abortion Federation About Ipas Ipas works globally so that women and girls have improved sexual and reproductive health and rights through enhanced access to and use of safe abortion and contraceptive care.